Aaron Rodgers’ tenure with the New York Jets began with lots of fanfare and Super Bowl aspirations. It ended less than two years later with a disappointing thud.

For 25 years, the University Area Community Development Corporation’s (CDC) Prodigy Cultural Arts Program has enriched the ...

today announced the presentation of a trial-in-progress poster on the Company’s first-in-human clinical trial evaluating FOG-001, the first and only direct inhibitor of β-catenin TCF4 ...

On the one hand, social media has democratised access to audiences, removing what were once gatekeepers to sharing your art, like galleries and academies ... Social media allows me to share finished ...

This advertisement has not loaded yet, but your article continues below. There’s only one sure way to beat the February blahs, and you don’t have to dress in layers, or dress at all, to enjoy ...

26 x 18 in. (66 x 45.7 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...

including a trial-in-progress poster on the ongoing pivotal Phase 3 clinical trial exploring the use of mavorixafor, an oral CXCR4 antagonist, for the treatment of people with chronic neutropenia (CN) ...

This moment has been heavy on my mind for many weeks. Frankly, I’d assumed that the flop sweat — the kind of sudden, heavy perspiration that only great embarrassment can cause — would have ...

We look forward to sharing progress with investigators and leaders at the conference.” About BXQ-350 Bexion’s lead drug candidate is BXQ-350, a first-in-class biologic containing the multifunctional, ...